摘要
作者对72例NHL的治疗方法与预后的关系进行临床探讨。本组结外NHL居多占70.8%,Ⅲ、Ⅳ期病人占45.8%。所有病例均经病理证实。其中22例接受扩大野放射治疗(R组);50例接受放化疗综合治疗(RC)组。全组3、5、10、15和>18年生存率分别为61.1%、54.0%、43.8%、35.0%和31.3%。其中R组3、5、10、15和18年以上生存率分别为59.1%、53.2%、23.3%、11.1%和(0/5);RC组分别为61.4%、57.7%、53.2%、41.1%和38.3%。尽管RC组病情较R组严重,但其各年生存率均高于R组,尤以10年以上生存差别显著。初步结果显示放化疗综合治疗NHL是提高远期生存率的有效方法之一。
Theraputic result of 72 patients with non Hodgkin's lymphomas (NHL) are evaluated. 70.8% of the cases were out of the lymph nodes, 45.8% at Ⅲ、Ⅳstage. Allpathologically comfirmed. 22 patients received extansion field radiotherapy (R); 50 pa-tients received radiotherapy combined with chemotherapy (RC). The overall survivalrates of 3、5、10、15 and>18yean were 61.1 %、54.0%、43.8%、35.0% 、and 31.3%, respectively. the 3、5 、10、15 and >18 year survival rates were 59.1%、53.2%、23.3%、11.l% and (0/5)in R group; 61.4% 、57.7% 、53.2% 、41.1% and 38.3% in RC group,re-spectively. Although the condition of the patients in RC group was more severe than Rgroup, The long term survival rates in RC group were higher than those in R group.The preliminary results shown that radiotherapy combined with chemotherapy is moreeffective in improving long term survival rates for NHL than radiotherapy alone.
出处
《肿瘤防治研究》
CAS
CSCD
北大核心
1998年第3期201-203,共3页
Cancer Research on Prevention and Treatment
关键词
淋巴瘤
NHL
放射疗法
药物疗法
lymphoma
non-Hodgkin's
Radio-Chemotherapy
Long-term survival